These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 25419568)
21. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473 [TBL] [Abstract][Full Text] [Related]
22. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750 [TBL] [Abstract][Full Text] [Related]
23. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer. Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633 [TBL] [Abstract][Full Text] [Related]
24. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line. Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368 [TBL] [Abstract][Full Text] [Related]
25. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. Liu H; Cadaneanu RM; Lai K; Zhang B; Huo L; An DS; Li X; Lewis MS; Garraway IP Prostate; 2015 May; 75(7):764-76. PubMed ID: 25663004 [TBL] [Abstract][Full Text] [Related]
26. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B; Cavard C; Perret C J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402 [TBL] [Abstract][Full Text] [Related]
27. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807 [TBL] [Abstract][Full Text] [Related]
29. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines. Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162 [TBL] [Abstract][Full Text] [Related]
30. Establishment of two basal-like breast cancer cell lines with extremely low tumorigenicity from Taiwanese premenopausal women. Kuo WL; Ueng SH; Wu CH; Lee LY; Lee YS; Yu MC; Chen SC; Yu CC; Tsai CN Hum Cell; 2018 Apr; 31(2):154-166. PubMed ID: 29484537 [TBL] [Abstract][Full Text] [Related]
31. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657 [TBL] [Abstract][Full Text] [Related]
32. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas. Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187 [TBL] [Abstract][Full Text] [Related]
34. Stem cells in mammary development and carcinogenesis: implications for prevention and treatment. Dontu G; Liu S; Wicha MS Stem Cell Rev; 2005; 1(3):207-13. PubMed ID: 17142857 [TBL] [Abstract][Full Text] [Related]
35. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Lopez-Bonet E; Menendez JA Oncol Rep; 2011 Jan; 25(1):135-40. PubMed ID: 21109968 [TBL] [Abstract][Full Text] [Related]
36. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Han ME; Jeon TY; Hwang SH; Lee YS; Kim HJ; Shim HE; Yoon S; Baek SY; Kim BS; Kang CD; Oh SO Cell Mol Life Sci; 2011 Nov; 68(21):3589-605. PubMed ID: 21448722 [TBL] [Abstract][Full Text] [Related]
37. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast. Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H Mol Cancer Res; 2019 Jul; 17(7):1556-1570. PubMed ID: 30992305 [TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line. Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205 [TBL] [Abstract][Full Text] [Related]
39. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation. Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135 [TBL] [Abstract][Full Text] [Related]
40. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]